• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清胱抑素C和肾小管尿酶作为2型糖尿病肾功能不全的生物标志物。

Serum cystatin C and tubular urinary enzymes as biomarkers of renal dysfunction in type 2 diabetes mellitus.

作者信息

Assal Heba S, Tawfeek Salwa, Rasheed Enas A, El-Lebedy Dalia, Thabet Eman H

机构信息

Department of Internal Medicine, Medical Research Division, National Research Centre, Egypt.

出版信息

Clin Med Insights Endocrinol Diabetes. 2013 Jul 31;6:7-13. doi: 10.4137/CMED.S12633. eCollection 2013.

DOI:10.4137/CMED.S12633
PMID:23966807
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3738377/
Abstract

Renal tubulointerstitium plays an important role in the development and progression of diabetic nephropathy. The aim of this study was to assess serum cystatin C and 2 renal tubular enzymes, neutrophil gelatinase associated lipocalin (NGAL) and N-acetyl-beta-D-glucosaminidase (NAG), as screening markers for early renal dysfunction in patients with type 2 diabetes mellitus (T2DM). ROC curve analysis showed that urinary NAG is the most sensitive marker of microalbuminuria and early renal damage with sensitivity of 83.3%, while serum cystatin C was the most sensitive and specific marker of macroalbuminuria and damage progress with sensitivity of 70.8% and specificity of 83.3% versus 70.6% and 83.3% for uNGAL; and 64.7% and 66.7% for NAG, respectively. Our data indicate that urinary NAG is the most sensitive marker for early renal damage in diabetic patients. However, for damage progress, serum cystatin C is the most sensitive and specific marker for follow-up and monitoring renal dysfunction.

摘要

肾小管间质在糖尿病肾病的发生和发展中起重要作用。本研究的目的是评估血清胱抑素C以及两种肾小管酶,即中性粒细胞明胶酶相关脂质运载蛋白(NGAL)和N-乙酰-β-D-氨基葡萄糖苷酶(NAG),作为2型糖尿病(T2DM)患者早期肾功能不全的筛查指标。ROC曲线分析表明,尿NAG是微量白蛋白尿和早期肾损伤最敏感的指标,敏感性为83.3%,而血清胱抑素C是大量白蛋白尿和损伤进展最敏感和特异的指标,敏感性为70.8%,特异性为83.3%,相比之下,尿NGAL的敏感性和特异性分别为70.6%和83.3%;NAG的敏感性和特异性分别为64.7%和66.7%。我们的数据表明,尿NAG是糖尿病患者早期肾损伤最敏感的指标。然而,对于损伤进展,血清胱抑素C是随访和监测肾功能不全最敏感和特异的指标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6805/3738377/4b24fa68d3bd/cmed-6-2013-007f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6805/3738377/f2954ec41a41/cmed-6-2013-007f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6805/3738377/4b24fa68d3bd/cmed-6-2013-007f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6805/3738377/f2954ec41a41/cmed-6-2013-007f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6805/3738377/4b24fa68d3bd/cmed-6-2013-007f2.jpg

相似文献

1
Serum cystatin C and tubular urinary enzymes as biomarkers of renal dysfunction in type 2 diabetes mellitus.血清胱抑素C和肾小管尿酶作为2型糖尿病肾功能不全的生物标志物。
Clin Med Insights Endocrinol Diabetes. 2013 Jul 31;6:7-13. doi: 10.4137/CMED.S12633. eCollection 2013.
2
Serum cystatin C and urinary enzymes as screening markers of renal dysfunction in diabetic patients.血清胱抑素C和尿酶作为糖尿病患者肾功能不全的筛查标志物。
J Nephrol. 2005 Sep-Oct;18(5):559-67.
3
Urinary tubular biomarkers in short-term type 2 diabetes mellitus patients: a cross-sectional study.短期 2 型糖尿病患者的尿肾小管标志物:一项横断面研究。
Endocrine. 2012 Feb;41(1):82-8. doi: 10.1007/s12020-011-9509-7. Epub 2011 Jul 21.
4
Evaluation of early biomarkers of renal dysfunction in diabetic patients.糖尿病患者肾功能不全早期生物标志物的评估。
Saudi Med J. 2020 Jul;41(7):690-697. doi: 10.15537/smj.2020.7.25168.
5
Urinary -acetyl-beta-d-glucosaminidase (NAG) with neutrophil gelatinase-associated lipocalin (NGAL) improves the diagnostic value for proximal tubule damage in diabetic kidney disease.尿β-N-乙酰氨基葡萄糖苷酶(NAG)联合中性粒细胞明胶酶相关脂质运载蛋白(NGAL)可提高糖尿病肾病近端肾小管损伤的诊断价值。
3 Biotech. 2019 Mar;9(3):66. doi: 10.1007/s13205-019-1593-z. Epub 2019 Feb 4.
6
Serum NGAL, cystatin C and urinary NAG measurements for early diagnosis of contrast-induced nephropathy in children.血清中性粒细胞明胶酶相关脂质运载蛋白、胱抑素C及尿N-乙酰-β-D-氨基葡萄糖苷酶检测用于儿童对比剂肾病的早期诊断
Ren Fail. 2016;38(1):27-34. doi: 10.3109/0886022X.2015.1106846. Epub 2015 Nov 20.
7
Performance of urinary neutrophil gelatinase-associated lipocalin, clusterin, and cystatin C in predicting diabetic kidney disease and diabetic microalbuminuria: a consecutive cohort study.尿中性粒细胞明胶酶相关脂质运载蛋白、簇集蛋白和胱抑素C在预测糖尿病肾病和糖尿病微量白蛋白尿中的表现:一项连续队列研究。
BMC Nephrol. 2017 Jul 12;18(1):233. doi: 10.1186/s12882-017-0620-8.
8
Utility of urinary biomarkers as a diagnostic tool for early diabetic nephropathy in patients with type 2 diabetes mellitus.尿生物标志物作为2型糖尿病患者早期糖尿病肾病诊断工具的效用。
Diabetes Metab Syndr. 2018 Sep;12(5):649-652. doi: 10.1016/j.dsx.2018.04.017. Epub 2018 Apr 12.
9
Novel urinary biomarkers in pre-diabetic nephropathy.糖尿病前期肾病中的新型尿液生物标志物。
Clin Exp Nephrol. 2015 Oct;19(5):895-900. doi: 10.1007/s10157-015-1085-3. Epub 2015 Jan 30.
10
NGAL and cystatin C: two possible early markers of diabetic nephropathy in young patients with type 1 diabetes mellitus: one year follow up.中性粒细胞明胶酶相关脂质运载蛋白(NGAL)和胱抑素C:1型糖尿病年轻患者糖尿病肾病的两种可能早期标志物:一年随访
Hormones (Athens). 2015 Apr-Jun;14(2):232-40. doi: 10.14310/horm.2002.1520.

引用本文的文献

1
Early Detection of Diabetic Nephropathy Based on Urinary and Serum Biomarkers: An Updated Systematic Review.基于尿液和血清生物标志物的糖尿病肾病早期检测:一项更新的系统评价
Adv Biomed Res. 2024 Oct 28;13:104. doi: 10.4103/abr.abr_461_23. eCollection 2024.
2
Pathomechanisms of Diabetic Kidney Disease.糖尿病肾病的发病机制
J Clin Med. 2023 Nov 27;12(23):7349. doi: 10.3390/jcm12237349.
3
Association between continuous glucose monitoring-derived glycemic control indices and urinary biomarkers of diabetic kidney disease: Hyogo Diabetes Hypoglycemia Cognition Complications study.

本文引用的文献

1
Glomerular and tubular damage markers are elevated in patients with diabetes.肾小球和肾小管损伤标志物在糖尿病患者中升高。
Diabetes Care. 2011 Apr;34(4):975-81. doi: 10.2337/dc10-1545. Epub 2011 Feb 9.
2
Regression of microalbuminuria in type 1 diabetes is associated with lower levels of urinary tubular injury biomarkers, kidney injury molecule-1, and N-acetyl-β-D-glucosaminidase.1 型糖尿病患者微量白蛋白尿的消退与尿肾小管损伤生物标志物、肾损伤分子-1 和 N-乙酰-β-D-氨基葡萄糖苷酶的水平降低有关。
Kidney Int. 2011 Feb;79(4):464-70. doi: 10.1038/ki.2010.404. Epub 2010 Oct 27.
3
Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Kidney Injury Molecule 1 (KIM1) in patients with diabetic nephropathy: a cross-sectional study and the effects of lisinopril.
连续血糖监测衍生的血糖控制指标与糖尿病肾病尿生物标志物的关系:兵库县糖尿病低血糖认知并发症研究。
Acta Diabetol. 2024 Apr;61(4):413-423. doi: 10.1007/s00592-023-02214-9. Epub 2023 Nov 25.
4
Evaluation of N-acetyl-β-D-glucosaminidase as a prognostic marker for diabetic nephropathy in type 2 diabetics: systematic review and meta-analysis.评价 N-乙酰-β-D-氨基葡萄糖苷酶作为 2 型糖尿病患者糖尿病肾病的预后标志物:系统评价和荟萃分析。
Int Urol Nephrol. 2024 May;56(5):1651-1661. doi: 10.1007/s11255-023-03843-3. Epub 2023 Oct 29.
5
Significance of Diabetic Kidney Disease Biomarkers in Predicting Metabolic-Associated Fatty Liver Disease.糖尿病肾病生物标志物在预测代谢相关脂肪性肝病中的意义
Biomedicines. 2023 Jul 7;11(7):1928. doi: 10.3390/biomedicines11071928.
6
Comparative diagnostic utility of different urinary biomarkers during pre-albuminuric stages of non-hypertensive type 2 diabetic nephropathy.比较非高血压 2 型糖尿病肾病白蛋白尿前阶段不同尿生物标志物的诊断效用。
Indian J Med Res. 2022 Jul;156(1):46-55. doi: 10.4103/ijmr.IJMR_455_21.
7
Diagnostic value of serum cystatin C for diabetic nephropathy: a meta-analysis.血清胱抑素 C 对糖尿病肾病的诊断价值:一项荟萃分析。
BMC Endocr Disord. 2022 Jun 2;22(1):149. doi: 10.1186/s12902-022-01052-0.
8
Urinary IgG, serum CX3CL1 and miRNA-152-3p: as predictors of nephropathy in Egyptian type 2 diabetic patients.尿 IgG、血清 CX3CL1 和 miRNA-152-3p:埃及 2 型糖尿病患者肾病的预测因子。
Tissue Barriers. 2022 Jul 3;10(3):1994823. doi: 10.1080/21688370.2021.1994823. Epub 2021 Oct 23.
9
Current Challenges and Future Perspectives of Renal Tubular Dysfunction in Diabetic Kidney Disease.糖尿病肾病中肾小管功能障碍的当前挑战和未来展望。
Front Endocrinol (Lausanne). 2021 Jun 10;12:661185. doi: 10.3389/fendo.2021.661185. eCollection 2021.
10
Non-Albumin Proteinuria (NAP) as a Complementary Marker for Diabetic Kidney Disease (DKD).非白蛋白蛋白尿(NAP)作为糖尿病肾病(DKD)的补充标志物
Life (Basel). 2021 Mar 10;11(3):224. doi: 10.3390/life11030224.
中性粒细胞明胶酶相关脂质运载蛋白 (NGAL) 和肾损伤分子 1 (KIM1) 在糖尿病肾病患者中的作用:一项横断面研究及赖诺普利的影响。
Diabet Med. 2010 Oct;27(10):1144-50. doi: 10.1111/j.1464-5491.2010.03083.x.
4
Screening for diabetes and pre-diabetes with proposed A1C-based diagnostic criteria.采用基于 A1C 的诊断标准筛查糖尿病和糖尿病前期。
Diabetes Care. 2010 Oct;33(10):2184-9. doi: 10.2337/dc10-0433. Epub 2010 Jul 16.
5
Serum cystatin C is a potential endogenous marker for the estimation of renal function in male gout patients with renal impairment.血清胱抑素 C 是估算男性肾功能受损痛风患者肾功能的潜在内源性标志物。
J Korean Med Sci. 2010 Jan;25(1):42-8. doi: 10.3346/jkms.2010.25.1.42. Epub 2009 Dec 26.
6
Changes of serum and urine neutrophil gelatinase-associated lipocalin in type-2 diabetic patients with nephropathy: one year observational follow-up study.2型糖尿病肾病患者血清和尿液中性粒细胞明胶酶相关脂质运载蛋白的变化:一年观察性随访研究
Endocrine. 2009 Aug;36(1):45-51. doi: 10.1007/s12020-009-9187-x. Epub 2009 Apr 24.
7
Neutrophil gelatinase-associated lipocalin as an early biomarker of nephropathy in diabetic patients.中性粒细胞明胶酶相关载脂蛋白作为糖尿病肾病的早期生物标志物。
Kidney Blood Press Res. 2009;32(2):91-8. doi: 10.1159/000209379. Epub 2009 Mar 24.
8
Urinary biomarkers for sensitive and specific detection of acute kidney injury in humans.用于人类急性肾损伤的敏感和特异的尿生物标志物。
Clin Transl Sci. 2008 Dec;1(3):200-8. doi: 10.1111/j.1752-8062.2008.00053.x.
9
Comparing measures of cystatin C in human sera by three methods.采用三种方法比较人血清中胱抑素C的检测指标。
Am J Nephrol. 2009;29(5):381-91. doi: 10.1159/000168486. Epub 2008 Oct 31.
10
Cystatin C improves the diagnosis and stratification of chronic kidney disease, and the estimation of glomerular filtration rate in diabetes.胱抑素C可改善慢性肾脏病的诊断和分层,以及糖尿病患者肾小球滤过率的评估。
Diabetes Metab. 2008 Nov;34(5):482-9. doi: 10.1016/j.diabet.2008.03.004. Epub 2008 Aug 13.